Product Not Found
The report you are looking for is no longer available. Here are some similar reports:
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update
Published Apr 30, 2014 by GlobalData - $9995
Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies
Published May 12, 2014 by GBI Research - $3500
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options
Published May 12, 2014 by GBI Research - $3500
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017
Published Mar 27, 2014 by GlobalData - $5995
OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017
Published Dec 31, 2013 by GlobalData - $5995
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies
Published Sep 30, 2013 by GBI Research - $3500
Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth
Published Dec 15, 2013 by GBI Research - $3500
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
Published Feb 28, 2014 by GlobalData - $9995
Gastric Cancer - Pipeline Review, H1 2014
Published May 30, 2014 by Global Markets Direct - $2000
MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
Published May 05, 2014 by GlobalData - $6495